Bkemv 300 MG per 30 ML Injection
- RxCUI
- 2706358
- RxNorm name
- Bkemv 300 MG per 30 ML Injection
- Display name
- Bkemv 300 MG per 30 ML Injection
- Full name
- Bkemv 300 MG per 30 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:45
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761333 | Bkemv | eculizumab-aeeb | 351(k) Interchangeable | Rx | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BKEMV | ECULIZUMAB-AEEB | Amgen Inc | 002f9748-b0e8-4b6e-a38b-56930a839491 | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | 2706358 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 002f9748-b0e8-4b6e-a38b-56930a839491 | BKEMV 300 MG in 30 ML Injection [PSN] · 30 ML eculizumab-aeeb 10 MG/ML Injection [Bkemv] [SBD] · Bkemv 300 MG per 30 ML Injection [SY] | 3 | 7 | These highlights do not include all the information needed to use BKEMV safely and effectively. See full prescribing information for BKEMV. BKEMV ® (eculizumab-aeeb) injection, for intravenous use Initial U.S. Approval: 2024 BKEMV (eculizumab-aeeb) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences between the b | 20251201 |